Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
1 additional grant classified as “Other” (multi-disciplinary, infrastructure, etc.).
Funding by Fiscal Year
NIH fiscal year (Oct–Sep)
$249K
FY23
$683K
FY26
By Funding Mechanism
R21
2
R00
1
Funding Gap Analysis
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Candidiasis, Invasive. Strongest funded area: Biomarker / Diagnostics. Largest gap: Epidemiology / Natural History.
Clinical ResearchTrials Active, No NIH Grants
7 clinical trials registered but no NIH-funded clinical or translational research grants found for candidiasis, invasive. Trials may be industry-sponsored or funded through non-NIH sources.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
7 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for candidiasis, invasive. Existing research activity suggests this may be a viable area for grant applications.
